Drug developer Akeso has raised nearly $150 million in Series D financing. Loyal Valley Capital and Sino Biopharmaceutical Co. Ltd led the round.
Source: Press Release
Drug developer Akeso has raised nearly $150 million in Series D financing. Loyal Valley Capital and Sino Biopharmaceutical Co. Ltd led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination